Visceral leishmaniasis (VL) is one of the most devastating diseases of the tropical region
caused by protozoan parasite Leishmania donovani. So far, there is no effective drug and …

Leishmaniasis is a neglected tropical disease, caused by several species of Leishmania.
Being an opportunistic lipid-scavenging pathogen, Leishmania relies extensively on lipid …

Leishmaniasis is a group of neglected infectious diseases, with approximately 1. 3 million
new cases each year, for which the available therapies have serious limitations. Therefore, it …

Visceral leishmaniasis is a neglected tropical disease and is mainly caused by L. donovani
in the Indian subcontinent. The mitochondria genome replication in Leishmania spp. is …

Leishmaniasis is a parasitic infectious neglected tropical disease transmitted to humans by
the parasites of Leishmania species. Mainly, three types of leishmaniases are usually …

Since many of the currently available antileishmanial treatments exhibit toxicity, low
effectiveness, and resistance, search and validation of new therapeutic targets allowing the …

Leishmaniases are neglected parasitic diseases in spite of the major burden they inflict on
public health. The identification of novel drugs and targets constitutes a research priority. For …

The amino acid hypusine (Nε-4-amino-2-hydroxybutyl (lysine)) occurs only in isoforms of
eukaryotic translation factor 5A (eIF5A) and has a role in initiating protein translation …

Visceral leishmaniasis (VL) is a neglected tropical disease that mainly affects the poor
population of the Indian, African, and South American subcontinent. The increasing …

Background: Visceral leishmaniasis (VL) is a tropical neglected disease, which encounters
poorest of poor people living in Asia, Africa and Latin America; causing the mortality of more …